Literature DB >> 7882218

Markedly elevated serum CA 19-9 levels in a case of chronic pancreatitis.

E M Yoshida1, C H Scudamore, S R Erb, D A Owen, H K Silver.   

Abstract

Serum levels of carbohydrate antigen (CA) 19-9 exceeding 1000 U/mL are considered highly specific for pancreatic cancer and have not been reported in nonmalignant pancreatic disease. A young man with obstructive jaundice, a serum CA 19-9 level of 2350 U/mL and a mass in the head of the pancreas, seen on computed tomography, was found to have chronic pancreatitis without malignant disease. This case demonstrates that a markedly elevated serum level of CA 19-9 can occur in nonmalignant pancreatic disease and emphasizes the need for a histologic diagnosis of malignancy even if the clinical diagnosis of pancreatic cancer seems certain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882218

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  3 in total

1.  Biliary tract obstruction in chronic pancreatitis.

Authors:  Abdul A Abdallah; Jake E J Krige; Philippus C Bornman
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 2.  Molecular markers of pancreatic cancer: development and clinical relevance.

Authors:  Lucia C Fry; Klaus Mönkemüller; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2008-02-12       Impact factor: 3.445

3.  Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer.

Authors:  Yusuke Yoshioka; Manami Shimomura; Keigo Saito; Hideshi Ishii; Yuichiro Doki; Hidetoshi Eguchi; Tetsuya Nakatsura; Takao Itoi; Masahiko Kuroda; Masaki Mori; Takahiro Ochiya
Journal:  Cancer Sci       Date:  2022-08-11       Impact factor: 6.518

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.